People: ACADIA Pharmaceuticals Inc (ACAD.O)

ACAD.O on Nasdaq

37.97USD
27 Feb 2015
Change (% chg)

$0.19 (+0.50%)
Prev Close
$37.78
Open
$36.87
Day's High
$38.48
Day's Low
$36.87
Volume
1,406,171
Avg. Vol
1,323,364
52-wk High
$38.48
52-wk Low
$15.64

Search Stocks

Kaplan, Lester 

Brief Biography

Dr. Lester J. Kaplan, Ph.D., is Independent Director of ACADIA Pharmaceuticals, Inc. Dr. Kaplan was Executive Vice President and President, Research and Development, at Allergan, Inc. from November 2003 to April 2004. Dr. Kaplan joined Allergan in 1983 and, prior to being appointed to Executive Vice President, was Corporate Vice President, Research and Development and Global BOTOX from June 1998 to November 2003. Dr. Kaplan was elected to Allergan’s board of directors in 1994 and served in that capacity until April 2004. Dr. Kaplan is Executive Chairman of the Board of Aciex Therapeutics Inc., and a member of the boards of Neurotech Pharmaceuticals, Inc. and The Foundation Fighting Blindness Clinical Research Institute. He serves on the Scientific Advisory Board of Bay City Capital. The NCG Committee believes that Dr. Kaplan’s long tenure as a board member and chair of Compensation Committee allows him to contribute his extensive knowledge of the Company and to provide Board and compensation continuity. In addition, the NCG Committee believes that his research and development expertise and venture capital background position him to make an effective contribution to the Board’s evaluation of strategic and financial alternatives. In particular, as the Company pursues its Phase III program for its lead compound, Dr. Kaplan’s prior experience with clinical trials and other development activities provide invaluable insight for the Board. Dr. Kaplan received an M.S. and Ph.D. in organic chemistry from the University of California, Los Angeles.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leslie Iversen

--

Uli Hacksell

4,818,870

Stephen Davis

--

Roger Mills

2,876,290

Terrence Moore

2,452,450

Glenn Baity

2,135,770
As Of 30 Dec 2013
Search Stocks